Putting patients and their families first: Dr Corina Dutcus,...

Dr Corina Dutcus, senior vice president and oncology global clinical development lead at Eisai, discusses the data Eisai presented at ASCO 2025.

Enhancing anti-tumour activity: A post-ASCO conversation wit...

Redefining the future of melanoma treatment: Scancell's bold...

On nuclear medicine and oncology, SHINE Technologies

Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.

IMUNON at ASCO 2025: Changing the micro-tumour environment i...

Treating primary bone cancer: The potential of listeria-base...

In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.